Cancer, cardiovascular drugs likely to win Nobel Prize as week begins




Research into cancer or cardiovascular drugs could be in the running for the Nobel Prize in Medicine, to be announced on Monday. As global crises continue, the award seeks to inspire optimism. The potential laureates are American biologist Kevan Shokat, known for his work on the KRAS cancer gene, which offers hope for the treatment of hard cancers such as lung, colon and pancreatic tumours.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *